Trial Profile
Phase IIb study of KUR 211 in patients with diabetic foot ulcers
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs KUR 211 (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Kuros Biosciences
- 08 Mar 2016 New trial record